NCT01316757 Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer Status COMPLETED Phase PHASE2
NCT01301716 A Study of the Safety and Pharmacology of GDC-0980 in Combination With Either Paclitaxel and Carboplatin (With or Without Bevacizumab) or Pemetrexed and Cisplatin in Patients With Solid Tumors Status COMPLETED Phase PHASE1
NCT01295502 Cisplatin and Radiation Therapy Followed by Paclitaxel and Carboplatin in Treating Patients With Stage IB-IVA Cervical Cancer Status UNKNOWN Phase PHASE1
NCT01293630 A Dose-escalation Study of Ombrabulin in Combination With Paclitaxel and Carboplatin in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01289353 Concurrent Adjuvant Carboplatin and Accelerated Radiotherapy for Triple Negative Breast Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01287520 A Study of LY2090314 in Patients With Advanced or Metastatic Cancer Status COMPLETED Phase PHASE1
NCT01285609 Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Versus Placebo in Addition to Paclitaxel and Carboplatin Status COMPLETED Phase PHASE3
NCT01283334 A Study of Carboplatin, Cetuximab and RAD001 in Advanced Head and Neck Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01281514 A Study of Carboplatin, PLD and Everolimus in Certain Gynecologic Cancer Status COMPLETED Phase PHASE1
NCT01281176 High-Dose or Low-Dose Vorinostat in Combination With Carboplatin or Paclitaxel in Treating Patients With Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT01281150 Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT01280058 Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT01275664 Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer Status TERMINATED Phase NA
NCT01268059 A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Untreated, Advanced Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT01263782 BATTLE-FL: Front-Line Biomarker-Integrated Treatment Study in Non Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT01256268 Carboplatin/Taxol/Ridaforolimus in Endometrial, Ovarian and Solids Status COMPLETED Phase PHASE1
NCT01251874 Veliparib and Carboplatin in Treating Patients With HER2-Negative Metastatic Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT01249443 Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection Status TERMINATED Phase PHASE1
NCT01248962 Standard Infusion Carboplatin Versus Prophylactic Extended Infusion Carboplatin in Patients With Patients With Recurrent, Ovary, Fallopian Tube, and Primary Peritoneal Cancer Status COMPLETED Phase PHASE2